Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilhelm Roell

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
International Journal of Cardiology|November 25, 2017
Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic propertiesThomas Beiert, Vincent Knappe, Vedat Tiyerili, et al.
Nature Cell Biology|April 22, 2008
Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusionJens M Nygren, Karina Liuba, Martin Breitbach, et al.
Theranostics|April 14, 2025
Nanoparticle-assisted targeting of heart lesions with cardiac myofibroblasts: Combined gene and cell therapyMiriam Schiffer, Kevin Wagner, Esther Carls, et al.
Cardiovascular Research|August 13, 2008
Perlecan is critical for heart stabilityPhilipp Sasse, Daniela Malan, Michaela Fleischmann, et al.
Blood|May 8, 2007
Potential risks of bone marrow cell transplantation into infarcted heartsMartin Breitbach, Toktam Bostani, Wilhelm Roell, et al.
Circulation|May 22, 2002
Cellular cardiomyoplasty improves survival after myocardial injuryWilhelm Roell, Zhong J Lu, Wilhelm Bloch, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2009
Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticlesAndreas Hofmann, Daniela Wenzel, Ulrich M Becher, et al.
Biomaterials|November 28, 2017
Improved heart repair upon myocardial infarction: Combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytesAnnika Ottersbach, Olga Mykhaylyk, Alexandra Heidsieck, et al.
The Journal of Experimental Medicine|September 7, 2006
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardiumEugen Kolossov, Toktam Bostani, Wilhelm Roell, et al.
Scientific Reports|May 10, 2018
Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell couplingWilhelm Roell, Alexandra M Klein, Martin Breitbach, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|November 25, 2017
Chronic lower-dose relaxin administration protects from arrhythmia in experimental myocardial infarction due to anti-inflammatory and anti-fibrotic propertiesThomas Beiert, Vincent Knappe, Vedat Tiyerili, et al.
Nature Cell Biology|April 22, 2008
Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusionJens M Nygren, Karina Liuba, Martin Breitbach, et al.
Theranostics|April 14, 2025
Nanoparticle-assisted targeting of heart lesions with cardiac myofibroblasts: Combined gene and cell therapyMiriam Schiffer, Kevin Wagner, Esther Carls, et al.
Cardiovascular Research|August 13, 2008
Perlecan is critical for heart stabilityPhilipp Sasse, Daniela Malan, Michaela Fleischmann, et al.
Blood|May 8, 2007
Potential risks of bone marrow cell transplantation into infarcted heartsMartin Breitbach, Toktam Bostani, Wilhelm Roell, et al.
Circulation|May 22, 2002
Cellular cardiomyoplasty improves survival after myocardial injuryWilhelm Roell, Zhong J Lu, Wilhelm Bloch, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2009
Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticlesAndreas Hofmann, Daniela Wenzel, Ulrich M Becher, et al.
Biomaterials|November 28, 2017
Improved heart repair upon myocardial infarction: Combination of magnetic nanoparticles and tailored magnets strongly increases engraftment of myocytesAnnika Ottersbach, Olga Mykhaylyk, Alexandra Heidsieck, et al.
The Journal of Experimental Medicine|September 7, 2006
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardiumEugen Kolossov, Toktam Bostani, Wilhelm Roell, et al.
Scientific Reports|May 10, 2018
Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through heterotypic cell-cell couplingWilhelm Roell, Alexandra M Klein, Martin Breitbach, et al.
Pageof 4